Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid T…

November 10, 2020

Schwarze, J. K., Awada, G., Cras, L., Tijtgat, J., Forsyth, R., Dufait, I., Tuyaerts, S., Van Riet, I., & Neyns, B.

Latest articles